The store will not work correctly when cookies are disabled.
2-(4-((9H-carbazol-9-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-phenylethanone
ID: ALA4550154
PubChem CID: 155550424
Max Phase: Preclinical
Molecular Formula: C23H18N4O
Molecular Weight: 366.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Cn1cc(Cn2c3ccccc3c3ccccc32)nn1)c1ccccc1
Standard InChI: InChI=1S/C23H18N4O/c28-23(17-8-2-1-3-9-17)16-26-14-18(24-25-26)15-27-21-12-6-4-10-19(21)20-11-5-7-13-22(20)27/h1-14H,15-16H2
Standard InChI Key: IWLDOZJSJPHRDQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
20.2731 -19.3019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7040 -18.0370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9472 -18.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7514 -19.0100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3131 -18.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0653 -17.6121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2617 -17.4329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6124 -18.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8795 -18.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3397 -17.4110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5325 -17.5696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2681 -18.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8098 -18.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2613 -20.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9700 -20.5496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0471 -21.3699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.8517 -21.5530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2744 -20.8443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7311 -20.2234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0961 -20.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5716 -21.4440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3933 -21.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2254 -22.1929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8672 -22.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6882 -21.9716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0352 -21.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5551 -20.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7357 -20.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 1 1 0
1 3 1 0
2 9 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
1 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 15 2 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.42 | Molecular Weight (Monoisotopic): 366.1481 | AlogP: 4.32 | #Rotatable Bonds: 5 |
Polar Surface Area: 52.71 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.18 | CX LogP: 4.40 | CX LogD: 4.40 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.44 | Np Likeness Score: -1.19 |